Rathmell: A tough budget is an opportunity to make sure NCI is “doing what is best for the American public”

NCI’s new CCSG is the result of “thousands of hours” of listening, negotiations, surprises
New NOFO aims to shrink applications by 40%

Late next month, NCI is expected to publish the new criteria it uses to bestow designations on America’s network of cancer centers.

NCAB ad hoc working group seeks to define its role as it approves eight reissue concepts
“We could do a lot more than be another committee to check the RFAs before they go to the next level.”

Members of the National Cancer Advisory Board’s ad hoc Working Group on Extramural Research Concepts and Programs at a recent meeting struggled to define the new group’s the role and raised concerns about some initial growing pains.

Dinah Singer retires from NCI, remains at NIH as Scientist Emeritus

Dinah S. Singer is now an NIH Scientist Emeritus after retiring from NCI in June.

October 30, 2026

Vol.52 No.40

In Brief

University of Illinois’ Andrei Gartel receives NCI grant to study AML

NCI awarded a two-year $422,000 grant to University of Illinois Cancer Center member Andrei Gartel to examine what might influence differences in outcomes for some patients with acute myeloid leukemia, an aggressive blood cancer with persistently poor outcomes in which relapse is common.

October 30, 2026

Vol.52 No.40

Perspective

California’s Prop 38 is an historic approach to funding medical research, immunology
The $8.4B bond makes a long-term investment in a field with life-saving power

Throughout my career as a physician and scientist, I’ve seen ideas once considered impossible become breakthroughs that save lives. They happened because talented scientists had the resources, institutions, and sustained support to pursue ambitious ideas. Most importantly, they knew patients could not afford to wait.

October 23, 2026

Vol.52 No.39

By Arie S. Belldegrun

In Brief

OU receives $2.9M NCI grant to study opaganib to enhance CAR T-cell therapy in multiple myeloma

A University of Oklahoma physician-researcher recently received $2.9 million in funding from NCI to study whether RedHill Biopharma’s drug opaganib, given after CAR T-cell therapy, can help the immune cells fight cancer more effectively.

October 23, 2026

Vol.52 No.39

Rathmell: A tough budget is an opportunity to make sure NCI is “doing what is best for the American public”

YOU MAY BE INTERESTED IN

NCI’s new CCSG is the result of “thousands of hours” of listening, negotiations, surprises
New NOFO aims to shrink applications by 40%

NCAB ad hoc working group seeks to define its role as it approves eight reissue concepts
“We could do a lot more than be another committee to check the RFAs before they go to the next level.”

Dinah Singer retires from NCI, remains at NIH as Scientist Emeritus

University of Illinois’ Andrei Gartel receives NCI grant to study AML

California’s Prop 38 is an historic approach to funding medical research, immunology
The $8.4B bond makes a long-term investment in a field with life-saving power

OU receives $2.9M NCI grant to study opaganib to enhance CAR T-cell therapy in multiple myeloma

Renew today!

Subscriber content

Never miss an issue!

Login

Rathmell: A tough budget is an opportunity to make sure NCI is “doing what is best for the American public”

YOU MAY BE INTERESTED IN

NCI’s new CCSG is the result of “thousands of hours” of listening, negotiations, surprisesNew NOFO aims to shrink applications by 40%

NCAB ad hoc working group seeks to define its role as it approves eight reissue concepts“We could do a lot more than be another committee to check the RFAs before they go to the next level.”

Dinah Singer retires from NCI, remains at NIH as Scientist Emeritus

University of Illinois’ Andrei Gartel receives NCI grant to study AML

California’s Prop 38 is an historic approach to funding medical research, immunologyThe $8.4B bond makes a long-term investment in a field with life-saving power

OU receives $2.9M NCI grant to study opaganib to enhance CAR T-cell therapy in multiple myeloma

Never miss an issue!

Login

NCI’s new CCSG is the result of “thousands of hours” of listening, negotiations, surprises
New NOFO aims to shrink applications by 40%

NCAB ad hoc working group seeks to define its role as it approves eight reissue concepts
“We could do a lot more than be another committee to check the RFAs before they go to the next level.”

California’s Prop 38 is an historic approach to funding medical research, immunology
The $8.4B bond makes a long-term investment in a field with life-saving power